{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:12:25Z","timestamp":1791400345191,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,27]],"date-time":"2009-12-27T00:00:00Z","timestamp":1261872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/nm.2075","type":"journal-article","created":{"date-parts":[[2009,12,27]],"date-time":"2009-12-27T13:22:40Z","timestamp":1261920160000},"page":"111-115","source":"Crossref","is-referenced-by-count":363,"title":["A key role for orexin in panic anxiety"],"prefix":"10.1038","volume":"16","author":[{"given":"Philip L","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Truitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D","family":"Fitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela E","family":"Minick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Sanghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lil","family":"Tr\u00e4skman-Bendz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantha","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,27]]},"reference":[{"key":"BFnm2075_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","volume":"58","author":"AW Goddard","year":"2001","unstructured":"Goddard, A.W. et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch. Gen. Psychiatry 58, 556\u2013561 (2001).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm2075_CR2","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1176\/appi.ajp.161.12.2186","volume":"161","author":"AW Goddard","year":"2004","unstructured":"Goddard, A.W. et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am. J. Psychiatry 161, 2186\u20132193 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm2075_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(06)69418-X","volume":"368","author":"PP Roy-Byrne","year":"2006","unstructured":"Roy-Byrne, P.P., Craske, M.G. & Stein, M.B. Panic disorder. Lancet 368, 1023\u20131032 (2006).","journal-title":"Lancet"},{"key":"BFnm2075_CR4","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1523\/JNEUROSCI.0408-06.2006","volume":"26","author":"PL Johnson","year":"2006","unstructured":"Johnson, P.L. & Shekhar, A. Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors. J. Neurosci. 26, 7093\u20137104 (2006).","journal-title":"J. Neurosci."},{"key":"BFnm2075_CR5","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/sj.npp.1301621","volume":"33","author":"PL Johnson","year":"2008","unstructured":"Johnson, P.L., Truitt, W.A., Fitz, S.D., Lowry, C.A. & Shekhar, A. Neural pathways underlying lactate-induced panic. Neuropsychopharmacology 33, 2093\u20132107 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"BFnm2075_CR6","doi-asserted-by":"publisher","first-page":"9205","DOI":"10.1523\/JNEUROSCI.2491-06.2006","volume":"26","author":"A Shekhar","year":"2006","unstructured":"Shekhar, A. et al. Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. J. Neurosci. 26, 9205\u20139215 (2006).","journal-title":"J. Neurosci."},{"key":"BFnm2075_CR7","doi-asserted-by":"publisher","first-page":"9726","DOI":"10.1523\/JNEUROSCI.17-24-09726.1997","volume":"17","author":"A Shekhar","year":"1997","unstructured":"Shekhar, A. & Keim, S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J. Neurosci. 17, 9726\u20139735 (1997).","journal-title":"J. Neurosci."},{"key":"BFnm2075_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0028-3908(99)00215-4","volume":"39","author":"A Shekhar","year":"2000","unstructured":"Shekhar, A. & Keim, S.R. LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats. Neuropharmacology 39, 1139\u20131146 (2000).","journal-title":"Neuropharmacology"},{"key":"BFnm2075_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0091-3057(96)00077-9","volume":"55","author":"A Shekhar","year":"1996","unstructured":"Shekhar, A., Keim, S.R., Simon, J.R. & McBride, W.J. Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacol. Biochem. Behav. 55, 249\u2013256 (1996).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnm2075_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrn2092","volume":"8","author":"T Sakurai","year":"2007","unstructured":"Sakurai, T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 8, 171\u2013181 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm2075_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm1544","volume":"13","author":"C Brisbare-Roch","year":"2007","unstructured":"Brisbare-Roch, C. et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat. Med. 13, 150\u2013155 (2007).","journal-title":"Nat. Med."},{"key":"BFnm2075_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0091-3022(03)00028-1","volume":"24","author":"AV Ferguson","year":"2003","unstructured":"Ferguson, A.V. & Samson, W.K. The orexin\/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front. Neuroendocrinol. 24, 141\u2013150 (2003).","journal-title":"Front. Neuroendocrinol."},{"key":"BFnm2075_CR13","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) 4th edn. 429\u2013440 (American Psychiatric Association, Washington, DC, 2005)."},{"key":"BFnm2075_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1176\/ajp.143.4.495","volume":"143","author":"MR Liebowitz","year":"1986","unstructured":"Liebowitz, M.R. et al. Possible mechanisms for lactate's induction of panic. Am. J. Psychiatry 143, 495\u2013502 (1986).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm2075_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0006-3223(91)90069-X","volume":"30","author":"DS Cowley","year":"1991","unstructured":"Cowley, D.S., Dager, S.R., Roy-Byrne, P.P., Avery, D.H. & Dunner, D.L. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder. Biol. Psychiatry 30, 49\u201356 (1991).","journal-title":"Biol. Psychiatry"},{"key":"BFnm2075_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00004714-198602000-00001","volume":"6","author":"MR Liebowitz","year":"1986","unstructured":"Liebowitz, M.R. et al. Alprazolam in the treatment of panic disorders. J. Clin. Psychopharmacol. 6, 13\u201320 (1986).","journal-title":"J. Clin. Psychopharmacol."},{"key":"BFnm2075_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1176\/ajp.151.4.547","volume":"151","author":"JM Gorman","year":"1994","unstructured":"Gorman, J.M. et al. Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. Am. J. Psychiatry 151, 547\u2013553 (1994).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm2075_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1749-6632.2003.tb07090.x","volume":"985","author":"A Shekhar","year":"2003","unstructured":"Shekhar, A., Sajdyk, T.J., Gehlert, D.R. & Rainnie, D.G. The amygdala, panic disorder, and cardiovascular responses. Ann. NY Acad. Sci. 985, 308\u2013325 (2003).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm2075_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95, 322\u2013327 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2075_CR20","doi-asserted-by":"publisher","first-page":"R581","DOI":"10.1152\/ajpregu.00671.2002","volume":"285","author":"Y Kayaba","year":"2003","unstructured":"Kayaba, Y. et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R581\u2013R593 (2003).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnm2075_CR21","doi-asserted-by":"publisher","first-page":"RC168","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","volume":"21","author":"TC Chou","year":"2001","unstructured":"Chou, T.C. et al. Orexin (hypocretin) neurons contain dynorphin. J. Neurosci. 21, RC168 (2001).","journal-title":"J. Neurosci."},{"key":"BFnm2075_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbr.2004.07.012","volume":"157","author":"Y Ishii","year":"2005","unstructured":"Ishii, Y. et al. Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behav. Brain Res. 157, 331\u2013341 (2005).","journal-title":"Behav. Brain Res."},{"key":"BFnm2075_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/sj.npp.1301621","volume":"33","author":"PL Johnson","year":"2007","unstructured":"Johnson, P.L., Truitt, W.A., Fitz, S.D., Lowry, C.A. & Shekhar, A. Neural pathways underlying lactate-induced panic. Neuropsychopharmacology 33, 2093\u20132107 (2007).","journal-title":"Neuropsychopharmacology"},{"key":"BFnm2075_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.1175055","volume":"325","author":"R Rupprecht","year":"2009","unstructured":"Rupprecht, R. et al. Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325, 490\u2013493 (2009).","journal-title":"Science"},{"key":"BFnm2075_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1590\/S0100-879X2001000200001","volume":"34","author":"R Andreatini","year":"2001","unstructured":"Andreatini, R. et al. The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis. Braz. J. Med. Biol. Res. 34, 145\u2013154 (2001).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"BFnm2075_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0006-3223(02)01355-0","volume":"52","author":"ML Boshuisen","year":"2002","unstructured":"Boshuisen, M.L., Ter Horst, G.J., Paans, A.M., Reinders, A.A. & den Boer, J.A. rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol. Psychiatry 52, 126\u2013135 (2002).","journal-title":"Biol. Psychiatry"},{"key":"BFnm2075_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0006-3223(94)90040-X","volume":"35","author":"C Grillon","year":"1994","unstructured":"Grillon, C., Ameli, R., Goddard, A., Woods, S.W. & Davis, M. Baseline and fear-potentiated startle in panic disorder patients. Biol. Psychiatry 35, 431\u2013439 (1994).","journal-title":"Biol. Psychiatry"},{"key":"BFnm2075_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/da.10026","volume":"15","author":"S Ludewig","year":"2002","unstructured":"Ludewig, S., Ludewig, K., Geyer, M.A., Hell, D. & Vollenweider, F.X. Prepulse inhibition deficits in patients with panic disorder. Depress. Anxiety 15, 55\u201360 (2002).","journal-title":"Depress. Anxiety"},{"key":"BFnm2075_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","volume":"54","author":"RM Salomon","year":"2003","unstructured":"Salomon, R.M. et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry 54, 96\u2013104 (2003).","journal-title":"Biol. Psychiatry"},{"key":"BFnm2075_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.euroneuro.2007.01.005","volume":"17","author":"L Brundin","year":"2007","unstructured":"Brundin, L., Bjorkqvist, M., Petersen, A. & Traskman-Bendz, L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur. Neuropsychopharmacol. 17, 573\u2013579 (2007).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"BFnm2075_CR31","doi-asserted-by":"publisher","first-page":"R472","DOI":"10.1152\/ajpregu.00667.2003","volume":"287","author":"BC Samuels","year":"2004","unstructured":"Samuels, B.C., Zaretsky, D.V. & DiMicco, J.A. Dorsomedial hypothalamic sites where disinhibition evokes tachycardia correlate with location of raphe-projecting neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R472\u2013R478 (2004).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnm2075_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0091-3057(96)00077-9","volume":"55","author":"A Shekhar","year":"1996","unstructured":"Shekhar, A., Keim, S.R., Simon, J.R. & McBride, W.J. Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacol. Biochem. Behav. 55, 249\u2013256 (1996).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnm2075_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-2999(03)01278-0","volume":"463","author":"SF De Boer","year":"2003","unstructured":"De Boer, S.F. & Koolhaas, J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur. J. Pharmacol. 463, 145\u2013161 (2003).","journal-title":"Eur. J. Pharmacol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2075","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:24:54Z","timestamp":1684434294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,27]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFnm2075"],"URL":"https:\/\/doi.org\/10.1038\/nm.2075","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2365956.8345054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.2365956.1994054","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,27]]}}}